Indonesia DIA-RAMADAN Study: A Real-life, Prospective and Observational of Gliclazide MR in Type-2 Diabetes Patients During Ramadan Fasting

Background: Sulfonylureas (SUs) have been widely used in many countries for T2DM treatment. Gliclazide is one of the SUs with the lowest risk of hypoglycemia; however, the safety and effectiveness of gliclazide MR during Ramadan has not yet been reported in Indonesia. This study aimed to assess safe...

Full description

Bibliographic Details
Main Authors: Soebagijo Adi Soelistijo, Andi Makbul Aman, Hendra Zufry, Agung Pranoto, Achmad Rudijanto, Mohamed Hassanien
Format: Article
Language:English
Published: Interna Publishing 2022-01-01
Series:Acta Medica Indonesiana
Subjects:
Online Access:https://www.actamedindones.org/index.php/ijim/article/view/1758